Summary:
Elligo Clinical Research Center is enrolling adults for a clinical research study to test the safety and effectiveness of an investigational flu vaccine.
Qualified Participants Must:
Be at least 18 years old
Have not received a Flu Vaccine within the last six (6) months
Able to attend all scheduled study visits and comply with all study-related procedures
Qualified Participants May Receive:
- Advance flu vaccine research
- Be compensated up to $115 per in office visit for your time
Overall, this study will consist of up to 8 study visits and one (1) phone call over a period of one (1) year. Other criteria will be determined to see if you are eligible. Reimbursement may be provided.